Publications by authors named "B S Bajwa"

Introduction: Every industry has greenhouse gas emissions, with healthcare a significant contributor. In Canada, the healthcare sector is directly and indirectly responsible for 4.6% of the country's greenhouse gas emissions.

View Article and Find Full Text PDF

Babesiosis, an emerging tick-borne zoonosis caused by parasites of the genus Babesia, is typically transmitted via the black-legged tick. Occasionally, can also be transmitted through red blood cell transfusion. In this report, we present a case of babesiosis resulting from a red blood cell transfusion in an area where the pathogen is not endemic.

View Article and Find Full Text PDF
Article Synopsis
  • The research presents a new method for analyzing glycosidic linkages in polysaccharides from five types of brown seaweed, focusing on structuring their alcohol-insoluble residues (AIRs).
  • This method utilizes GC-MS analysis of partially methylated alditol acetates (PMAAs) to identify variations in fucose linkages across different seaweed species, harvest years, and treatments, revealing significant structural diversity.
  • It also improves cellulose quantification by addressing shortcomings in traditional methods, and introduces a pretreatment that helps detect uronic acid linkages in alginates more effectively.
View Article and Find Full Text PDF

Syphilis is a sexually transmitted infection that is undergoing a resurgence in Canada and around the world. If not diagnosed correctly, syphilis can progress to its secondary and tertiary stages, affecting numerous organ systems. We present a case of a 41-year-old female who developed a papulosquamous rash, initially diagnosed as varicella with progression to a widespread and painful rash over 3 months.

View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis is a common, chronic skin condition that causes itchy, red, and scaly patches, affecting around 20% of children and 7-14% of adults, depending on the country.
  • The condition arises from a combination of genetic, immune, and environmental factors, leading researchers to discover new treatment options targeting inflammation to alleviate symptoms.
  • Current treatments range from standard options like emollients and corticosteroids to newer therapies such as biologics (e.g., dupilumab) and small molecule inhibitors, each with specific mechanisms and varying effectiveness and safety profiles.
View Article and Find Full Text PDF